DHX9-IN-16 (208) is a RNA helicase DHX9 inhibitor, with an EC50 of 0.125 μM in DHX9 cellular target engagement. Used in cancer research[1].
References
[1] Matthew H, et al.Matthew H, et al. Inhibitors of rna helicase dhx9 and uses thereof. Patent WO2023154519. Inhibitors of rna helicase dhx9 and uses thereof. Patent WO2023154519.
